MedPath

The effects of intravenous TRH administration on brown adipose tissue activity in healthy, lean men.

Completed
Conditions
Obesitas
Obesity
10052547
Registration Number
NL-OMON41582
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

Male sex
Age between 30 and 50 years old
BMI range 19 to 25 kg/m2

Exclusion Criteria

Treated or untreated hypo- or hyperthyroidism
Renal dysfunction (eGFR >60)
Use of any medication known to affect thyroid hormone metabolism or the autonomic nervous system
Any cardiovascular disease
Recent stay of >2 weeks in the tropics within the last 6 weeks
The desire to conceive within 1 month

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The degree of 18F-FDG uptake in BAT, skin temperature, blood pressure, heart<br /><br>rate, and serum TSH, T3, T4, FT4, norepinephrine and normetanephrine after TRH<br /><br>administration, compared to saline administration;</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The association between BAT acitvity and changes in blood pressure, heart rate,<br /><br>and serum TSH, T3, T4, FT4, norepinephrine and normetanephrine.</p><br>
© Copyright 2025. All Rights Reserved by MedPath